A recalled sexual enhancement supplement hid sildenafil and tadalafil, FDA says

A&P Creations LLC has pulled its biQ-FEL liquid supplement off the market nationwide after the U.S. Food and Drug Administration found the product contained undeclared sildenafil and tadalafil, the prescription ingredients in Viagra and Cialis. The Clermont, Florida company announced the recall on September 14, 2026, and the FDA published its own notice describing the contamination the following day. Neither drug was listed on the label of the 500-milliliter bottle, which was marketed as a natural sexual-enhancement liquid.

The company’s notice covers two lots sold under the biQ-FEL name: lot biQ-f001-06-25, expiring May 6, 2027, and lot biQ-003-01-26, expiring January 1, 2028, carrying UPC 7709799120663. Both were sold to consumers directly through the internet between December 15, 2024, and June 11, 2026, according to the recall filing.

Lab Testing Turned Up Two Hidden Prescription Drugs

A&P Creations issued the recall after FDA laboratory analysis confirmed undeclared sildenafil and tadalafil in biQ-FEL. Both compounds are approved prescription drugs for erectile dysfunction, sold under the brand names Viagra and Cialis, and neither is legal to include in a product marketed as a dietary supplement without disclosure. The recall notice describes biQ-FEL as sold in a 500-milliliter bottle with Spanish-language labeling, including the phrase “Sabor artificial Hierbabuena,” and distributed through Amazon, Walmart.com and the company’s own online storefront, branded Nature Fuel.

The FDA’s notice does not explain how the ingredients ended up in the formulation, and A&P Creations has not said whether the contamination was deliberate or the result of a manufacturing error. What the agency has confirmed is the chemistry: unauthorized PDE5 inhibitors of this kind are a recurring contaminant in over-the-counter products claiming to boost sexual performance, and their presence is almost always undisclosed until laboratory testing catches it. Because biQ-FEL was sold only online rather than through a pharmacy or a brick-and-mortar retailer, the recall notice’s lot numbers and expiration dates are the only practical way for a past buyer to confirm whether the bottle sitting in a medicine cabinet is one of the affected units.

Nitrate Interactions Are the Central Danger

The FDA’s core warning centers on what happens when sildenafil or tadalafil reaches someone taking a nitrate medication. The undeclared drugs “may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels,” the agency said in its recall notice. Nitroglycerin and related nitrates are commonly prescribed for chest pain and heart disease, and the combination with a PDE5 inhibitor can cause blood pressure to fall sharply and suddenly.

People with diabetes, high blood pressure, high cholesterol or heart disease face elevated risk from the hidden drugs even without a nitrate prescription, according to the FDA, because those underlying conditions already affect cardiovascular regulation. A&P Creations said no adverse events had been reported in connection with biQ-FEL as of the September 14 announcement, and the recall was carried out voluntarily with the FDA’s knowledge rather than under a mandatory order.

Consumers who purchased the affected lots are advised to stop using the product immediately and dispose of it rather than return it. A&P Creations has set up a dedicated customer-service email address, staffed Monday through Friday from 9 a.m. to 4 p.m. Eastern, for questions about the recall, and the FDA is directing anyone who experienced a reaction to file a report through its MedWatch adverse-event system rather than relying on the retailer that sold the product.

The Same Manufacturer’s Other Product Was Also Flagged

A&P Creations markets a second item, the X10 Natural Enhancement Supplement, sold as individually wrapped 15-milliliter sachets, that the FDA separately flagged for hidden drug ingredients. Fox 10 Phoenix reported that both the biQ-FEL and X10 products were sold through Amazon and Walmart, putting two supplements from the same small manufacturer in front of federal regulators within the same recall cycle.

Scripps News, covering the same recall, reported that the sales window for the tainted products ran from December 2024 through June 2026, a stretch of roughly eighteen months during which consumers could have purchased either item without any indication it carried a prescription drug. That timeline matters because sildenafil and tadalafil both carry contraindications that a supplement buyer, working from a label listing only herbal ingredients, would have had no way to check against their own medications. A person managing blood pressure with a nitrate prescription, for instance, would have no reason to disclose that medication to anyone before buying what was marketed as an herbal liquid.

Neither A&P Creations nor the FDA has identified how many bottles of biQ-FEL reached consumers during that window, and the recall notice does not include a total unit count, only the two lot numbers and their expiration dates. That leaves the scope of potential exposure defined by distribution channel and time period rather than by a firm number of units sold.

The FDA maintains a running list of tainted sexual enhancement products it has identified through testing, a catalog that now numbers in the hundreds of individual notifications dating back years. The agency’s own caveat on that page is blunt: the list “covers only a small fraction of the contaminated products on the market,” and its absence from the database is not proof that any given supplement is safe. For a category of products sold largely online with minimal pre-market screening, that gap between what has been tested and what remains on shelves is the practical risk the biQ-FEL recall illustrates.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

More from Morning Overview